US Stock MarketDetailed Quotes
ACIU AC Immune
- 3.180
- -0.230-6.74%
Close May 17 16:00 ET
- 3.250
- +0.070+2.20%
Post 19:19 ET
314.50MMarket Cap-4725P/E (TTM)
3.400High3.095Low550.83KVolume3.375Open3.410Pre Close1.80MTurnover1.24%Turnover RatioLossP/E (Static)98.90MShares5.14052wk High1.97P/B141.77MFloat Cap1.90052wk Low--Dividend TTM44.58MShs Float19.970Historical High--Div YieldTTM8.94%Amplitude1.680Historical Low3.268Avg Price1Lot Size
AC Immune Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 106.09%1.02M | 17.89%-60.41M | 6.99%-16.19M | 1.75%-13.3M | 27.54%-14.12M | 27.40%-16.8M | -11.99%-73.57M | 2.36%-17.41M | 6.63%-13.54M | -21.58%-19.48M |
| Net income from continuing operations | -1.99%-17.86M | 23.35%-54.23M | 74.70%-4.74M | -12.05%-15.14M | 14.30%-16.83M | 7.08%-17.51M | 3.07%-70.75M | 11.88%-18.75M | 15.09%-13.52M | -3.00%-19.64M |
| Operating gains losses | -62.88%49K | 64.14%888K | 308.75%327K | -98.31%3K | 326.00%426K | -27.87%132K | -10.28%541K | -42.03%80K | 14.84%178K | -35.48%100K |
| Depreciation and amortization | -2.46%556K | -6.10%2.22M | -8.26%555K | -5.18%549K | -5.91%541K | -5.00%570K | -1.95%2.36M | -3.66%605K | -9.11%579K | -3.04%575K |
| Other non cash items | -5,450.00%-2.03M | 638.24%1.1M | 592.63%1.32M | -201.43%-211K | 84.80%-45K | 235.71%38K | 96.71%-204K | 111.56%190K | 98.40%-70K | -166.67%-296K |
| Change In working capital | 1,333.79%18.11M | -79.79%-15.16M | -3,687.82%-14.62M | 138.34%467K | 150.00%462K | 75.14%-1.47M | -223.26%-8.43M | -111.30%-386K | -132.35%-1.22M | -177.39%-924K |
| -Change in receivables | 90,875.00%14.52M | -2,566.00%-14.87M | -531.52%-14.95M | 107.41%260K | 53.04%-162K | -101.62%-16K | 21.82%603K | 468.23%3.47M | -777.03%-3.51M | -318.35%-345K |
| -Change in prepaid assets | 441.93%2.52M | -1.75%-1.75M | 41.60%-907K | -184.86%-370K | 133.80%266K | -496.24%-737K | -317.19%-1.72M | -40.04%-1.55M | -43.30%436K | -244.40%-787K |
| -Change in payables and accrued expense | 308.47%1.13M | 126.53%1.91M | 160.55%1.44M | -61.86%669K | 523.64%343K | 91.80%-543K | -240.10%-7.19M | -148.48%-2.38M | -35.80%1.75M | -92.63%55K |
| -Change in other working capital | 62.79%-64K | -245.38%-449K | -359.74%-200K | -192.93%-92K | -90.20%15K | 62.53%-172K | -130.59%-130K | -86.40%77K | 138.98%99K | 160.00%153K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 106.09%1.02M | 17.89%-60.41M | 6.99%-16.19M | 1.75%-13.3M | 27.54%-14.12M | 27.40%-16.8M | -11.99%-73.57M | 2.36%-17.41M | 6.63%-13.54M | -21.58%-19.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -155.05%-23.56M | 176.25%65.65M | 369.45%23.28M | 192.17%4.72M | -121.07%-5.16M | 8,025.93%42.8M | 144.28%23.76M | 122.83%4.96M | -934.55%-5.12M | 179.80%24.47M |
| Net PPE purchase and sale | -24.50%-249K | 35.35%-801K | -304.88%-166K | -131.40%-280K | 71.14%-155K | 62.96%-200K | 52.98%-1.24M | 94.32%-41K | 75.56%-121K | 14.49%-537K |
| Net investment purchase and sale | -154.09%-23.26M | 165.78%66.45M | 368.92%23.45M | 200.00%5M | -120.00%-5M | --43M | 149.02%25M | 123.81%5M | ---5M | --25M |
| Net other investing changes | ---54K | ---- | ---- | ---- | ---- | ---- | 106.90%2K | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -155.05%-23.56M | 176.25%65.65M | 369.45%23.28M | 192.17%4.72M | -121.07%-5.16M | 8,025.93%42.8M | 144.28%23.76M | 122.83%4.96M | -934.55%-5.12M | 179.80%24.47M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -387.94%-688K | 3,313.22%43.25M | 27,270.86%41.03M | 415.49%448K | 1,497.81%1.92M | 84.61%-141K | -103.30%-1.35M | -100.53%-151K | -103.28%-142K | -621.05%-137K |
| Net issuance payments of debt | -23.70%-167K | 3.69%-548K | 2.80%-139K | 2.80%-139K | 4.93%-135K | 4.26%-135K | -102.48%-569K | -100.61%-143K | 0.69%-143K | -21.37%-142K |
| Net common stock issuance | 133.33%2K | 4,379,900.00%43.8M | 514,687.50%41.17M | 58,600.00%587K | 40,900.00%2.05M | -700.00%-6K | -100.01%-1K | -100.15%-8K | -99.98%1K | 118.52%5K |
| Net other financing activities | ---523K | ---- | ---- | ---- | ---- | ---- | -12,833.33%-776K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -387.94%-688K | 3,313.22%43.25M | 27,270.86%41.03M | 415.49%448K | 1,497.81%1.92M | 84.61%-141K | -103.30%-1.35M | -100.53%-151K | -103.28%-142K | -621.05%-137K |
| Net cash flow | ||||||||||
| Beginning cash position | 148.51%78.49M | -61.58%31.59M | -28.26%31.93M | -36.64%40.01M | -0.69%57.43M | -61.58%31.59M | -48.90%82.22M | -52.45%44.5M | -39.36%63.15M | -61.72%57.84M |
| Current changes in cash | -189.82%-23.23M | 194.79%48.49M | 481.91%48.12M | 56.74%-8.13M | -458.08%-17.36M | 205.12%25.86M | 34.93%-51.15M | -16.47%-12.6M | -76.21%-18.8M | 110.38%4.85M |
| Effect of exchange rate changes | 17,500.00%1.74M | -403.07%-1.58M | -387.42%-1.55M | -66.67%52K | -115.27%-71K | -104.59%-10K | 844.29%521K | 42.29%-318K | 32.20%156K | 280.23%465K |
| End cash Position | -0.74%57.01M | 148.51%78.49M | 148.51%78.49M | -28.26%31.93M | -36.64%40.01M | -0.69%57.43M | -61.58%31.59M | -61.58%31.59M | -52.45%44.5M | -39.36%63.15M |
| Free cash flow | 104.56%775K | 18.18%-61.21M | 6.25%-16.36M | 0.57%-13.58M | 28.71%-14.27M | 28.21%-17M | -9.49%-74.81M | 5.94%-17.45M | 8.91%-13.66M | -20.22%-20.02M |
| Currency Unit | CHF | CHF | CHF | CHF | CHF | CHF | CHF | CHF | CHF | CHF |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg